Olanzapine efficacy in the treatment of essential tremor

European Journal of Neurology

Volumn 10, Issue 1, 2003, Pages 79-82

  Yetimalar, Y ^a,b   Irtman, G ^a   Gurgor N ^a   Basoglu M ^a  

^a Izmir Ataturk Education Hospital   (Turkey)

^b Üçkuyular Izmir ^*  (Turkey)

Author keywords

Drug therapy; Essential tremor; Movement disorders; Olanzapine

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; OLANZAPINE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ESSENTIAL TREMOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SEDATION; SELF EVALUATION; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

AGED; BENZODIAZEPINES; CHI-SQUARE DISTRIBUTION; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE; PROSPECTIVE STUDIES;

EID: 0037238065     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00534.x     Document Type: Article

References (15)

1. Bain P (1993). A combined clinical and neurophysiological approach to the study of patients with tremor. J Neurol Neurosurg Psychiatry 69:839-844.
2. Biary N, BahouY, Sofi MA (1995). The effect of nimodipine on essential tremor. Neurology 45:1523-1525.
3. Bonucelli U, Ceravolo R, Salvetti S (1997). Clozapine in Parkinson's disease tremor. Effects of acute and chronic administration. Neurology 48:1077-1081.
4. Cerevolo R, Savletti S, Dell'Agnello G (1997). Pharmocological tools in the study of essential tremor. Mov Disord 11:255.
5. Elble RJ, Higginns C, Hughes L (1992). Longitudinal study of essential tremor. Neurology 42:441-443.
6. Friedman JH, Koller WC, Lannon MC (1989). Benztropine versus clozapine for the treatment of tremor in Parkinson's disease. Neurology 48:1077-1081.
7. Friedman JH, Lannon MC (1990). Clozapine-responsive tremor in Parkinson's disease. Mov Disord 5:225-229.
8. Jansen EN (1994). Clozapine in the treatment of tremor in Parkinson's disease. Acta Neurol Scand 89:262-265.
9. Jiménez NG, Hargreave M (2000). Topiramate and essential tremor. Ann Neurol 47:837-838.
10. Koller WC, Deuschl G (2000). Essential tremor. Neurology 54:2-45.
11. Koller WC, Busenbark K, Miner K (1994). The relationship of essential tremor to the other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol 35:717-723.
12. Louis EC, Ottman R, Hauser WA (1998). How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disor 13:5-10.
13. Pakkenberg H, Pakkenberg B (1986). Clozapine in the treatment of tremor. Acta Neurol Scand 3:295-297.
14. Wasielewski PG, Burns JM, Koller WC (1998). Pharmacologic treatment of tremor. Mov Disord 3:90-100.
15. Watts RL, Koller WC (1997). Movement Disorders. Neurologic Principles and Practice. Mc Graw-Hill Companies, New York, pp. 366-381.